the idea of removing toxic substances from the bloodstream was not new, Kolff was the first to devise practical equipment for this purpose (Fig 1) . The patient's blood was passed from a cannula in the radial artery into a long tube of cellophane sausage-skin which was wound around a supporting drumshaped framework. The frame rotated on a spindle so that the blood-filled tubing was bathed in a tank containing dialysis fluid. The cleansed blood was returned by another cannula inserted into a convenient larae vein and the process repeated until the biochemical abnormalities were considerably ameliorated. The blood was prevented from clotting by repeated injection of heparin into the blood circuit. Kolff went on to devise an improved artificial kidney in which the cellophane tubing is contained within a compact coil, the necessary large surface area provided by two tubes, the bloodstream being divided into two to supply each tube. This design was capable of being manufactured and sterilized ready for use -the first disposable kidney. In all coil dialysers the dialysis fluid is pumped around the blood-filled dialysis membrane, rather than the tubing itself being rotated through a stationary bath of dialysis fluid. The coil is supported in a container and the dialysis fluid is pumped through the coil and splashes back into the bath to be recirculated again. Fig 2 shows the twin-coil kidney with which we began our service for renal failure in Belfast in 1959. Several other forms of artificial kidney have been devised. These include flat plate dialysers in which two sheets of dialysis membrane are sandwiched between plates of polypropylene which are engraved with grooves, along which the dialysis fluid is pumped and passed to waste. The prototype of this was designed by Kiil in 1960 and uses two such sandwiches. The artificial kidney now most widely used is the capillary kidney in which the blood is passed through enormous numbers of capillary tubes made of dialysis membrane, around which the dialysis fluid is pumped.
After the War, Kolff gave artificial kidneys to Hammersmith Hospital in London, Mount Sinai Hospital in New York, and the Royal Victoria Hospital in Montreal, all of whom reported successful treatments. Sadly the kidney which he gave to Amsterdam was never used. The artificial kidney stimulated interest in the kidney, its functions and its diseases. At Hammersmith Hospital there was very active interest in the kidney when Dr Graham Bull came as a Research Fellow from Cape Town in 1948. He was involved, with Milne, Borst and others, in the early use of the artificial kidney. By his accounts the original Kolff with its wooden tank and framework was difficult to set up and patients developed convulsions and rigors during treatment. He became more interested in water and electrolyte balance and the dietary management of renal failure, and published seminal papers with Borst and Milne.1 2 They developed the subsequently famous Bull-Borst diet, a protein-free regimen which provided energy as pure carbohydrate and oil. The aim was to provide enough energy to prevent wasting of body tissues, thus sparing nitrogen production, without giving sodium and potassium. The diet was difficult to take, the patients became nauseated by the mixture of glucose or lactose and oil, and developed sore mouths. Equally important was the concept of fluid restriction, because patients with uraemia become thirsty, and, if allowed to drink freely, develop oedema and then heart failure. Graham choice of the City Hospital for the siting of the new service was due to the late Mr John Megaw (Fig 3) . I was given the task of setting up the service, with the grade of Junior Hospital Medical Officer, in 1958, to be elevated to Senior Hospital Medical Officer in 1960. The artificial kidney arrived one day in early June 1959 but the ward was not ready for occupation for another nine months. It happened that a GP refresher course was being held at the City Hospital two days later and Mr Megaw, always an enthusiast, insisted that I should set it up and demonstrate it to the GPs. By this time a technician, Mr Maurice Bingham, had been recruited from the Biochemistry Laboratory to assist me. I had seen a twin coil once; he had never seen one at all. The pair of us read the booklet, which came with the apparatus, and proceeded to set it up using red ink to mimic the blood circuit, much to the satisfaction of Mr Megaw and his class of GPs. Meantime, Dr Eliahou from Israel, who was finishing a year's attachment with Professor Bull. Iearned of the arrival of our eauinment and wanted to see it in action before departing for home. Professor Welbourn tied the ureters of a dog and we waited 48 hours for it to become uraemic. Our first haemodialysis was carried out in the animal theatre in the Department of Surgery. We managed to give the dog a short dialysis, enough to demonstrate a satisfactory fall in blood urea. Dr Eliahou returned to Israel where he later set up the Renal Unit in Tel Aviv, and he is now a world expert on acute renal failure. At this point, I felt that I was ready to visit the Renal Unit at Halton to see how dialysis should really be carried out. However, the following week an elderly man was admitted in uraemia due to prostatism. He was semicomatose with a blood urea over 600 mg/100 ml. Mr Megaw demanded that I should treat him by dialysis. 'You dialysed a dog last week, you cannot let my patient die without trying'. Mr Maurice Bingham and I set up the twin coil kidney in Ava 2 theatre (which no longer exists) and Miss Eileen Martin, the Medicine Department technician, weighed out three sets of chemicals to make up three changes of the dialysis fluid. Mr Megaw inserted the cannulae in the radial artery and cephalic vein, and in fear and trepidation we treated our first patient. My stepson, John Freeland, sat in my car at the front of the Ava to act as messenger. When I wanted to send a blood sample to the laboratory, or when I needed to have an extra set of chemicals weighed out after I had stupidly spoilt one bath of dialysis fluid, I just stuck my head out of the window and hollered for him to come up. It was a very successful treatment in that the blood urea fell from around 600 mg/100 ml to 200 mg/100 ml after about six hours, and the patient wakened up. Unfortunately he died within a week from a cerebrovascular accident. From then on we were in business. We were still without the promised accommodation in Ward 9, and our headquarters consisted of a small room in Ward 15 formerly used as a store. The hospital van took us and the kidney to the patient, most often to the Royal Victoria Hospital where we dialysed many times in the classroom between Wards 1 and 2, and 3 and 4, in the old ward theatres and later in Ward 22 where Dr Gray was beginning to provide ventilation for patients with respiratory failure. The second patient recovered from 36 days of virtual anuria and was well when I last heard of her a few years ago, more than 20 years later. Another early recovery from acute renal failure after an incompatible blood transfusion is working in the Wakehurst Unit. Not all the patients recovered but, looking back at those early days, the recovery rate seems to have been higher than it is now. This is probably because patients with grave injuries or illness are now resuscitated and live long enough to develop renal failure but may not survive other complications, sometimes dying after renal function has returned. And so I never got to Halton to see how dialysis should be done, and was entirely taught by the book.
There were many problems for our travelling dialysis service. Plugs never fitted and there always seemed to be a problem about the water supply. 1964 . The first patient died from septicaemia after a short time. This occurred because we attempted to make the treatment less expensive, re-using the twin coil by washing it free from blood with saline and storing it in the refrigerator between treatments. His brother was to become our first transplant later on. Both brothers had renal failure from polycystic disease. The second patient commenced treatment in January 1965, and soon became well enough to live at home, returning twice a week for treatment; thus we were able to keep her well but were prevented from accepting any new patient. She had a transplant in St Mary's Hospital, London, in 1965, which functioned well for seven years, eventually being lost due to a deep venous thrombosis which followed an aeroplane journey. This transplant led to a partnership with Professor Peart's unit and a regular small trickle of patients was sent to London for the transplant operation, returning to Belfast for long-term supervision of the immunosuppressive treatment necessary to prevent rejection of the graft. I will return to the transplant story later. By this time the flat plate kidney had appeared. This had several advantages for treatment of patients requiring regular haemodialysis, the most important of which was that the volume of the complete blood circuit was much less than that of the twin coil kidney. This meant that the kidney could be primed with saline instead of blood which was needed for the larger volume coils. Moreover the cost of the cupraphane membrane sheets was very little compared with coils costing £22.00 in 1965 money. An engineer in London called Heppel made a copy of the original Swedish model for treatment of his wife in the Royal Free Hospital. He later set up a small business to manufacture Kiil kidneys. He was kind enough to let me have two sets on the understanding that I would pay for them some time. We set to and taught ourselves how to build the brutes, by sweat and tears. Professor Love may remember finding me one Saturday literally in tears because the wretched kidney developed a leak every time it was tested. There were many new tricks to that trade which had to be learnt. The Kiil kidney is flushed by fresh dialysis fluid at the rate of half-a-litre per minute, and, as the treatments then lasted 14 hours, a large volume of dialysis fluid was required (Fig 4) . The necessary salts had to be weighed out and the fluid mix prepared in a huge plastic fish tank, containing 400 litres. We ordered our tank but it was not to be ready for several months so we set about treating two patients in a makeshift way using the 1 00-litre tank of the original coil kidney. The patients were treated at night so that the coil kidney could be used during the day for the acute service. Mr Megaw kindly lent us one of his two cystoscopy theatres for this purpose. The tank of fluid had to be replenished four times during the night. The service was possible only because Mr Jack Lyness volunteered to sleep on a couch in the surgeons' room four nights a week, to be awakened by the night nurse when the fluid level went down to a critical point. Mr Lyness did this in addition to his davtime duties for about six months until the new tanks arrived. The cleansing of the Kiil kidneys presented a problem. It is horrifying now to think that, oblivious to the perils of hepatitis B, the bloodstained Kiils were carried the length of Ward 9 to the bathroom at the far end where they were scrubbed in the patients' bath. The dialysis tanks had to be scrubbed and sterilised with hypochlorite and, on occasions, our washings leaked through to Casualty situated just beneath us. Attempts were made to control the outbreaks by testing sera from staff and patients regularly, dialysing infected patients in isolation and improving crossinfection precautions. Some centres trained patients with hepatitis for home dialysis but the disease sometimes spread to family members. Hepatitis B has a long incubation period, six weeks to six months, and these patients, unlike most other groups of patients receiving blood transfusion, return repeatedly to hospital, eventually becoming infective when viraemia develops. Staff and other patients become contaminated by spillage of blood or staff pricking themselves accidentally with contaminated needles. In Belfast we were fortunate to have the help of Dr John Connolly who set up the tests very quickly, and routine testing was instituted. Renal 11 was opened in May 1972 and from the beginning followed the practices recommended by the Rosenheim Committee. Despite this, we experienced hepatitis for the first time in July 1972. At the beginning of June, a patient with renal failure was admitted from a peripheral hospital, and as usual on admission had the hepatitis B antigen test carried out which was reported as negative. He soon required regular haemodialysis, and was prepared for the programme. He had his first haemodialysis in Renal 11 on 1 1 July, blood being taken for a second hepatitis B test on that day as part of the routine surveillance of the Unit. On account of the 'Twelfth' holidays, it was not until 15 July that it was discovered that the test was positive. It then became known that he had received transfusion the day before he came to us, and so must have been incubating the disease. In the meantime the patient had received a second haemodialysis in the normal way. He was then isolated in a side-ward and a list of volunteers was drawn up to treat him. Between 1968 and 1985, 347 patients have received 392 grafts, there being 38 second grafts, six third grafts and one fourth graft. Most of the grafts came from cadavers, only 36 coming from live donors. Two hundred and forty-five patients are alive with functioning grafts, and 11 others are alive, having returned to dialysis after failure of their graft. We had the good fortune to achieve outstandingly good results of patient and graft survival from the beginning of our transplantation programme, and over the years since statistics have been collected centrally, have been at the top of the 'league table'.6 Now after almost 17 years it is possible to identify at least some of the factors which contribute to our high success rate which has continued over all this time. The careful organisation of the team has resulted in good clinical care. The most important point in the preparation of the recipient is now known to be the giving of blood transfusion, which we have done from the beginning of our programme, despite the fact that transfusion was then beginning to be considered a risk factor rather than helpful. The drugs we have given to prevent rejection of the kidney were those in general use but we decided to use much lower doses, particularly of prednisolone, in the hope of reducing toxic side effects. We hoped to improve the results of transplantation by avoiding infection, particularly fatal infection. This we were able to do, by isolation of the patients through the use of the specially designed building, and by using very low doses of steroid compared with other centres.
THE PROBLEMS OF RENAL REPLACEMENT THERAPY I have described to you a truly marvellous story -the discovery of how the function of a vital organ may be replaced after failure, permitting life to continue for years. Indeed the kidney is the only organ where complete failure of function can be treated. Hard on the heels of this discovery came the development of renal transplantation. Successful transplantation restores the patient to almost complete normality. Machine treatment, dietary and fluid restriction become unnecessary and the patient merely has to take a few pills daily to prevent rejection. Normal energy is regained, indeed patients with transplants become fit, even for competitive sport. One patient starred in the recent victory of Clandeboye in the Irish Senior Cup Golf Competition. Parenthood is possible even for women. One patient has had three successful pregnancies since transplantation. Many others have had one child and several have had two. As soon as a new service develops, the demand for it grows rapidly. By the end of 1964 we were treating one patient. It was possible to squeeze in treatment for the first patient without detriment to the acute programme. The first patient died after a short time, and other patients followed one by one during 1965. Table 11 shows the number of patients receiving treatment from 1964 when we began regular haemodialysis until we moved to Renal I in 1968. The number of patients transplanted each year is also shown. Thanks to Professor Vallance-Owen, and the devoted work of Sister Wallace and the nursing staff of Wards 3 and 4 RVH, two patients were regularly given twice weekly peritoneal dialysis from 1968 until 1972 when Renal 11 was opened. After 1968 the numbers of patients treated increased slowly year by year (Table III) , but this in no way satisfied the demand. at the end of the year to be joined by 40 new patients appearing in the second year. In the third year 86 % of the first set of patients and 93 % of the second set of patients remain to be joined by the new ones. Even at the end of the third year, 80% of the first set of patients remain alive. The number of patients goes on increasing until eventually equilibrium is reached when the new patients are equalled by patients dying. The statisticians tell us that equilibrium will be reached only after 25 years, but 90% of steady state will be reached after 10 years. The cost of regular dialysis therapy, of course, escalates year by year as the number of patients increases. If the programme is expanded to include older people, diabetics and other disadvantaged patients, more will die each year, but in the meantime they will have had more medical complications and cost more to treat. It is difficult to arrive at a true cost but several years ago the DHSS costed hospital haemodialysis at £1 1 -13,000 per annum, and home dialysis at £6 -8,250 per annum. Home haemodialysis costs less but, if the patient receives a transplant, the cost of converting the home is lost and it takes two years of home treatment to break even. Satellite dialysis is nearly as cheap as home treatment and, as it avoids the cost of converting individual homes, it is the best buy. However, it is cheaper only because of the economy of staffing that becomes possible when only fit stable patients are treated. The saving in cost in the satellite is, to some extent, offset by increased costs in the mother unit which copes with the early problems, and accepts back patients who get into difficulties. Moreover, the older and otherwise disadvantaged patients are not suitable for treatment in a satellite centre.
Transplantation is cheaper but the immunosuppressive drugs cost about £1,200
per annum or more if cyclosporin is used. The saving is illusory as the transplanted patient is replaced by a new patient. The transplant often does not cover the life of the patient, who may need dialysis treatment again. While one of our patients has had a well-functioning graft for more than 20 years, and 47 for 12.15 years, the average is less than 10 years. Six patients have had three grafts and one a fourth graft. We must, however, remember that transplantation provides much better quality of life than any form of dialysis. While it is not possible for all patients the contraindications are relatively few. 
